Figure 1. Increasing Representation of Women in HF Clinical Trials Effectively addressing disparities that lead to underrepresentation of women in HF clinical trials requires multifaceted interventions involving investigators, sponsors, and regulators. An action-based approach should include: increasing the pool and offering more opportunities to female researchers; providing targeted training and mentorship programs to cultivate a diverse pool of skilled female researchers; intentional recruitment of women participants; policy changes; and an overall commitment to diversity, ensuring that women are adequately represented in all aspects of clinical research, from trial design to execution and analysis. HF = heart failure.
We only have this paper's title and publication details.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Blumer et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: